Agenus | Capital Social E Reservas





Capital Social e Reservas Alterar Data
AbbVie USD -2.64B 2.46B 2025-09
Agenus USD -274.14M 80.46M 2025-09
Amgen USD 9.62B 2.19B 2025-09
AstraZeneca USD 48.67B 2.78B 2025-12
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Celldex Therapeutics USD 598.36M 57.04M 2025-09
CSL USD 21.41B 861M 2025-06
Dynavax Technologies USD 534.14M 39.98M 2025-09
Eli Lilly USD 23.79B 5.52B 2025-09
Gilead Sciences USD 22.62B 1.16B 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
Glaxosmithkline GBP 21.7B 7.35B 2025-09
Incyte USD 5.17B 516.28M 2025-12
Intrexon USD 43.17M 75.33M 2024-06
J&J USD 78.47B 0 2025-09
Jiangsu Hengrui CNY 59.5B 814.63M 2025-09
Karyopharm Therapeutics USD -269.26M 30.33M 2025-09
MacroGenics USD 67M 20.38M 2025-09
Merck EUR 28.94B 677M 2025-09
Merck USD 51.85B 2.79B 2025-09
Novartis USD 44.75B 2.7B 2025-09
Novavax USD -156.67M 194.3M 2025-09
Pfizer USD 92.8B 4.11B 2025-09
Regeneron Pharmaceuticals USD 31.26B 299.1M 2025-12
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Veracyte USD 1.26B 36.61M 2025-09


Agenus Capital Social E Reservas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.